This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics

WEB REGISTRATION CLOSES:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
May 14-17, 2024 | In-Person + Digital
Boston, MA, USAHynes Convention Center

Frederic Legros, PhD
CEO at ARTHEx Biotech
Speaker

Profile

Dr. Frédéric Legros is an established biotech leader with more than 15 years of Corporate & Business Development experience in the biotechnology industry. Between January 2017 and October 2022, he served as Chief Operating Officer of Dynacure, a company he co-founded. Prior to launching Dynacure, and until December 2016, Dr. Legros served as Vice President and Corporate Head of Business Development of Valneva SE, a biotech company listed on the French stock exchange. Dr. Legros studied biotechnology and received his Ph.D. in molecular biology from University of Paris 7. He also holds a business degree from NEOMA Business School, France.

Agenda Sessions

  • Use of a Lipophilic-conjugation to Deliver antimiR-23b into Skeletal Muscle and Nervous System as a Dual Therapeutic Approach in DM1

    9:30am